Compounds > methionine sulfoximine
Page last updated: 2024-08-21

methionine sulfoximine and Malignant Melanoma

methionine sulfoximine has been researched along with Malignant Melanoma in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19904 (36.36)18.7374
1990's7 (63.64)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
del Marmol, V; Ghanem, G; Huez, G; Lejeune, F; Libert, A; Sels, A; Solano, F1
Bloomer, WD; Damodaran, KM; Prezioso, JA; Wang, N1
Bolognia, JL; Osber, MP; Pawelek, JM; Sodi, SA1
Alvero-Jackson, H; Benathan, M; Frenk, E; Mooy, AM; Scaletta, C1
Guenthner, TM; Jevtović-Todorović, V1
FitzGerald, GB; Prezioso, JA; Wick, MM1
Bloomer, WD; Epperly, MW; Prezioso, JA; Wang, N1
Brötell, H; Karg, E; Rorsman, H; Rosengren, E1
Favier, D; Kable, EP; Parsons, PG1
Edgren, M; Ehrsson, H; Hansson, J; Nilsson, B; Ringborg, U1
Guichard, M; Lespinasse, F; Malaise, EP1

Other Studies

11 other study(ies) available for methionine sulfoximine and Malignant Melanoma

ArticleYear
Glutathione depletion increases tyrosinase activity in human melanoma cells.
    The Journal of investigative dermatology, 1993, Volume: 101, Issue:6

    Topics: Antimetabolites, Antineoplastic; Buthionine Sulfoximine; Glutathione; Humans; Melanins; Melanoma; Methionine Sulfoximine; Monophenol Monooxygenase; Sulfhydryl Compounds; Time Factors; Tumor Cells, Cultured; Tyrosine 3-Monooxygenase

1993
Mechanism(s) regulating inhibition of thymidylate synthase and growth by gamma-L-glutaminyl-4-hydroxy-3-iodobenzene, a novel melanin precursor, in melanogenic melanoma cells.
    Biochemical pharmacology, 1993, Jan-26, Volume: 45, Issue:2

    Topics: Animals; Biotransformation; Buthionine Sulfoximine; Cell Division; Glutamine; Glutathione; GTP Phosphohydrolases; Humans; Melanins; Melanoma; Methionine Sulfoximine; Mice; Monophenol Monooxygenase; Oxidation-Reduction; Phenols; Protein Precursors; Tetrazolium Salts; Thiazoles; Thymidylate Synthase; Tumor Cells, Cultured

1993
Enhancement of the depigmenting effect of hydroquinone by cystamine and buthionine sulfoximine.
    The British journal of dermatology, 1995, Volume: 133, Issue:3

    Topics: Animals; Buthionine Sulfoximine; Cystamine; Drug Combinations; Drug Synergism; Enzyme Inhibitors; Guinea Pigs; Hair Color; Hydroquinones; Melanoma; Methionine Sulfoximine; Mice; Mice, Inbred C57BL; Monophenol Monooxygenase; Skin Pigmentation; Tumor Cells, Cultured

1995
Relationship between melanogenesis, glutathione levels and melphalan toxicity in human melanoma cells.
    Melanoma research, 1992, Volume: 2, Issue:5-6

    Topics: Bucladesine; Buthionine Sulfoximine; Cell Differentiation; Cell Division; Cell Survival; Dose-Response Relationship, Drug; Eye Neoplasms; Glutathione; Glutathione Transferase; Humans; Kinetics; Melanins; Melanoma; Melphalan; Methionine Sulfoximine; Microscopy, Electron; Monophenol Monooxygenase; Neoplasm Staging; Skin Neoplasms; Tumor Cells, Cultured

1992
Depletion of a discrete nuclear glutathione pool by oxidative stress, but not by buthionine sulfoximine. Correlation with enhanced alkylating agent cytotoxicity to human melanoma cells in vitro.
    Biochemical pharmacology, 1992, Oct-06, Volume: 44, Issue:7

    Topics: Buthionine Sulfoximine; Carmustine; Cell Division; Cell Nucleus; Cytosol; Doxorubicin; Drug Synergism; Glutathione; Glutathione Disulfide; Humans; Melanoma; Melphalan; Methionine Sulfoximine; Oxidation-Reduction; Tumor Cells, Cultured

1992
Melanoma cytotoxicity of buthionine sulfoximine (BSO) alone and in combination with 3,4-dihydroxybenzylamine and melphalan.
    The Journal of investigative dermatology, 1992, Volume: 99, Issue:3

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Buthionine Sulfoximine; Dopamine; Glutathione Peroxidase; Humans; Hydrogen Peroxide; Melanoma; Melanoma, Experimental; Melphalan; Methionine Sulfoximine; Mice; Tumor Cells, Cultured

1992
Effects of tyrosinase activity on the cytotoxicity of 4-S-cysteaminylphenol and N-acetyl-4-S-cysteaminylphenol in melanoma cells.
    Cancer letters, 1992, Mar-31, Volume: 63, Issue:1

    Topics: Antineoplastic Agents; Buthionine Sulfoximine; Cell Division; Cysteamine; Drug Synergism; Humans; Melanoma; Methionine Sulfoximine; Monophenol Monooxygenase; Phenols; Theophylline; Time Factors; Tumor Cells, Cultured

1992
Modulation of glutathione level in cultured human melanoma cells.
    Acta dermato-venereologica, 1989, Volume: 69, Issue:2

    Topics: Antimetabolites; Buthionine Sulfoximine; Cell Line; Cell Survival; Cysteine; Glutathione; Humans; Melanoma; Methionine Sulfoximine; Tumor Cells, Cultured; Vitamin K

1989
Sensitivity of human melanoma cells to L-dopa and DL-buthionine (S,R)-sulfoximine.
    Cancer research, 1989, May-01, Volume: 49, Issue:9

    Topics: Buthionine Sulfoximine; Cell Cycle; Cell Survival; Glutathione; Humans; Levodopa; Melanoma; Methionine Sulfoximine; Tumor Cells, Cultured

1989
Effect of D,L-buthionine-S,R-sulfoximine on cytotoxicity and DNA cross-linking induced by bifunctional DNA-reactive cytostatic drugs in human melanoma cells.
    Cancer research, 1988, Jan-01, Volume: 48, Issue:1

    Topics: Antineoplastic Agents; Buthionine Sulfoximine; Cell Division; Cell Survival; Cross-Linking Reagents; DNA; Drug Synergism; Glutathione; Humans; Melanoma; Melphalan; Methionine Sulfoximine; Tumor Cells, Cultured

1988
Influence of buthionine sulfoximine and misonidazole on glutathione level and radiosensitivity of human tumor xenografts.
    Radiation research, 1986, Volume: 105, Issue:1

    Topics: Adenocarcinoma; Animals; Buthionine Sulfoximine; Cell Line; Colonic Neoplasms; Female; Glutathione; Humans; Melanoma; Methionine Sulfoximine; Mice; Mice, Nude; Misonidazole; Neoplasm Transplantation; Neoplasms; Radiation Tolerance; Transplantation, Heterologous

1986